Ignite Creation Date:
2025-12-24 @ 9:38 PM
Ignite Modification Date:
2026-01-09 @ 11:21 AM
Study NCT ID:
NCT00479232
Status:
COMPLETED
Last Update Posted:
2015-09-21
First Post:
2007-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06
Start Date Type:
None
Primary Completion Date:
2010-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-05-24
First Submit QC Date:
None
Study First Post Date:
2007-05-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-04-28
Results First Submit QC Date:
None
Results First Post Date:
2011-08-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-09-04
Last Update Post Date:
2015-09-21
Last Update Post Date Type:
ESTIMATED